Lipocine Inc. Balance Sheet
LPCN|9 years of annual SEC 10-K data (FY2013-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 9 fiscal years. All figures from audited SEC 10-K filings.
Lipocine Inc. had $17M in total assets and $21M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.2M | $6.2M | $4.8M | $3.1M | $3.0M | $19.2M | $9.7M | $8.1M | $5.4M |
| Current Assets | $16.9M | $22.3M | $22.9M | $34.1M | $46.4M | $25.3M | $19.6M | $20.8M | $46.0M |
| PP&E (Net) | $104.3K | $165.1K | $116.1K | $131.6K | $7.2K | - | $3.6K | $19.0K | $28.8K |
| Total Assets | $17.0M | $22.5M | $23.0M | $37.5M | $52.5M | $25.4M | $19.7M | $20.9M | $46.1M |
| Current Liabilities | $2.5M | $1.5M | $2.6M | $1.7M | $5.6M | $6.6M | $5.0M | $4.5M | $1.3M |
| Total Debt | - | - | - | - | - | $2.3M | $3.8M | $6.9M | - |
| Shareholders' Equity | $21.0M | $20.4M | $35.6M | $45.6M | $15.3M | $6.3M | $9.4M | $19.0M | $5.3M |